Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics

被引:33
|
作者
Cepeda, M. Soledad [1 ]
Reps, Jenna [1 ]
Fife, Daniel [1 ]
Blacketer, Clair [1 ]
Stang, Paul [1 ]
Ryan, Patrick [1 ]
机构
[1] Janssen Res & Dev, Titusville, NJ USA
关键词
databases; decision tree; epidemiology; machine learning; prevalence; NATIONAL COMORBIDITY SURVEY; STAR-ASTERISK-D; MAJOR DEPRESSION; DEFINITION; PREVALENCE; OUTCOMES; EPIDEMIOLOGY; DISORDERS; DATABASES; TRIALS;
D O I
10.1002/da.22705
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Depression that does not respond to antidepressants is treatment-resistant depression (TRD). TRD definitions include assessments of treatment response, dose and duration, and implementing these definitions in claims databases can be challenging. We built a data-driven TRD definition and evaluated its performance. Methods: We included adults with depression, >= 1 antidepressant, and no diagnosis of mania, dementia, or psychosis. Subjects were stratified into those with and without proxy for TRD. Proxies for TRD were electroconvulsive therapy, deep brain, or vagus nerve stimulation. The index date for subjects with proxy for TRD was the procedure date, and for subjects without, the date of a randomly selected visit. We used three databases. We fit decision tree predictive models. We included number of distinct antidepressants, with and without adequate doses and duration, number of antipsychotics and psychotherapies, and expert-based definitions, 3, 6, and 12 months before index date. To assess performance, we calculated area under the curve (AUC) and transportability. Results: We analyzed 33,336 subjects with no proxy for TRD, and 3,566 with the proxy. Number of antidepressants and antipsychotics were selected in all periods. The best model was at 12 months with an AUC = 0.81. The rule transported well and states that a subject with >= 1 antipsychotic or >= 3 antidepressants in the last year has TRD. Applying this rule, 15.8% of subjects treated for depression had TRD. Conclusion: The definition that best discriminates between subjects with and without TRD considers number of distinct antidepressants (>= 3) or antipsychotics (>= 1) in the last year.
引用
收藏
页码:220 / 228
页数:9
相关论文
共 44 条
  • [1] A Real-World Data-Driven approach for estimating environmental impacts of traffic accidents
    Liao, Xishun
    Wu, Guoyuan
    Yang, Lan
    Barth, Matthew J.
    TRANSPORTATION RESEARCH PART D-TRANSPORT AND ENVIRONMENT, 2023, 117
  • [2] Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia
    Han, Changsu
    Wang, Gang
    Chan, Sandra
    Kato, Tadafumi
    Ng, Chee H.
    Tan, Wilson
    Zhang, Lili
    Feng, Yu
    Liu, Chia-Yih
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 2929 - 2941
  • [3] Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
    Jobnah, Sumaya
    Latifeh, Youssef
    Al Kabani, Dina
    Youssef, Lama A.
    BMC PSYCHIATRY, 2024, 24 (01)
  • [4] Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study
    Brendle, Madeline
    Ahuja, Sachin
    Della Valle, Maisa
    Moore, Claire
    Thielking, Paul
    Malone, Daniel C.
    Robison, Reid
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (18) : 1323 - 1336
  • [5] The Influence of Childhood Trauma on the Real-World Effectiveness of Ketamine in Adults With Treatment-Resistant Depression
    Johnson, Danica E.
    Rodrigues, Nelson B.
    Mansur, Rodrigo B.
    McIntyre, Roger S.
    Rosenblat, Joshua D.
    ACTA PSYCHIATRICA SCANDINAVICA, 2025,
  • [6] Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depression
    Johnson, Danica E.
    Rodrigues, Nelson B.
    Weisz, Sydney
    Chisamore, Noah
    Kaczmarek, Erica S.
    Chen-Li, David C. J.
    Doyle, Zoe
    Richardson, J. Don
    Mansur, Rodrigo B.
    Mcintyre, Roger S.
    Rosenblat, Joshua D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2025, 91 : 69 - 77
  • [7] Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
    Lipsitz, Orly
    Di Vincenzo, Joshua D.
    Rodrigues, Nelson B.
    Cha, Danielle S.
    Lee, Yena
    Greenberg, David
    Teopiz, Kayla M.
    Ho, Roger C.
    Cao, Bing
    Lin, Kangguang
    Subramaniapillai, Mehala
    Flint, Alastair J.
    Kratiuk, Kevin
    McIntyre, Roger S.
    Rosenblat, Joshua D.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (09) : 899 - 913
  • [8] Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis
    Doeme, Peter
    Kunovszki, Peter
    Takacs, Peter
    Feher, Laszlo
    Balazs, Tamas
    Dede, Karoly
    Mulhern-Haughey, Siobhan
    Barbreau, Sebastien
    Rihmer, Zoltan
    PLOS ONE, 2021, 16 (01):
  • [9] Evaluating real-world effectiveness of accelerated transcranial magnetic stimulation for treatment-resistant depression in a tertiary referral center based in Quebec, Canada
    Masse-Leblanc, Camille
    Jodoin, Veronique Desbeaumes
    Nguyen, Dang Khoa
    Fournier-Gosselin, Marie -Pierre
    Stip, Emmanuel
    Lesperance, Paul
    Miron, Jean Philippe
    PSYCHIATRY RESEARCH, 2024, 332
  • [10] Data-driven Semi-supervised Anomaly Detection using Real-World Call Data Record
    Jaffry, Shan
    Shah, Syed Tariq
    Hasan, Syed Faraz
    2020 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), 2020,